Suchergebnisse - "Saag, Michael S"

PubPharm (19)

1

Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment

enthalten in: AIDS (London, England) | 2016

von Stellbrink, H. | Le Fevre, E. | Carr, A. | +12

2

An Algorithm Approach to Determining Smoking Cessation Treatment for Persons Living With HIV/AIDS : Results of a Pilot Trial

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2015

von Cropsey, K. | Jardin, B. | Burkholder, G. | +3

3

Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP

enthalten in: The Journal of infectious diseases | 2014

von Boltz, V. | Bao, Y. | Lockman, S. | +35

CommentIn: J Infect Dis. 2014 Mar 1;209(5):639-41. - PMID 24273184

4

Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients : final 5-year results from STARTMRK

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2013

von Rockstroh, J. | DeJesus, E. | Lennox, J. | +80

5

Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009

enthalten in: PloS one | 2013

von Hanna, D. | Buchacz, K. | Gebo, K. | +97

6

Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients : week-192 overall and subgroup analyses from STARTMRK

enthalten in: HIV clinical trials | 2012

von DeJesus, E. | Rockstroh, J. | Lennox, J. | +80

ErratumIn: HIV Clin Trials. 2012 Sep-Oct;13(5):preceding 233

7

Comparative effectiveness of initial antiretroviral therapy regimens : ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2011

von Mugavero, M. | May, M. | Ribaudo, H. | +68

8

Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients : 156-week results from STARTMRK

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2011

von Rockstroh, J. | Lennox, J. | Dejesus, E. | +13

9

Phase 2a study of the CCR5 monoclonal antibody PRO 140 administered intravenously to HIV-infected adults

enthalten in: Antimicrobial agents and chemotherapy | 2010

von Jacobson, J. | Lalezari, J. | Thompson, M. | +10

10

Antiretroviral therapies in women after single-dose nevirapine exposure

enthalten in: The New England journal of medicine | 2010

von Lockman, S. | Hughes, M. | McIntyre, J. | +87

CommentIn: N Engl J Med. 2010 Oct 14;363(16):1570-2. - PMID 20942674